Avinger (NASDAQ:AVGR) Coverage Initiated at StockNews.com

Equities researchers at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR) in a report released on Wednesday. The firm set a “hold” rating on the medical device company’s stock.

Avinger Stock Up 11.2 %

Shares of Avinger stock opened at $0.60 on Wednesday. The stock has a market capitalization of $1.99 million, a price-to-earnings ratio of -0.05 and a beta of 1.15. Avinger has a twelve month low of $0.39 and a twelve month high of $5.45. The company has a 50-day simple moving average of $0.74 and a two-hundred day simple moving average of $0.97.

Avinger (NASDAQ:AVGR) last released its quarterly earnings results on Thursday, November 7th. The medical device company reported ($1.82) earnings per share for the quarter, beating analysts’ consensus estimates of ($2.03) by $0.21. The company had revenue of $1.65 million during the quarter, compared to the consensus estimate of $1.60 million. Avinger had a negative net margin of 261.06% and a negative return on equity of 5,527.11%. During the same period in the previous year, the business earned ($2.92) earnings per share. On average, sell-side analysts anticipate that Avinger will post -4.69 earnings per share for the current fiscal year.

Avinger Company Profile

Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.